Hochschulschrift
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
143, xxii, 57 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Ruperto-Carola University of Heidelberg, Dissertation, 2016
- Klassifikation
-
Medizin, Gesundheit
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Development of inhibitors of the prostate specific membrane antigen (PSMA) for imaging and endoradiotherapy
Expression of prostate specific membrane antigen (PSMA) in breast cancer : = Die Expression des prostataspezifischen Membranantigens (PSMA) beim Mammakarzinom
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Radiochemistry and preclinical PET imaging of 68Ga-desferrioxamine radiotracers targeting prostate-specific membrane antigen
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted \(^18}\)F-DCFPyL in peripheral ganglia
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Development of inhibitors of the prostate specific membrane antigen (PSMA) for imaging and endoradiotherapy
Expression of prostate specific membrane antigen (PSMA) in breast cancer : = Die Expression des prostataspezifischen Membranantigens (PSMA) beim Mammakarzinom
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Radiochemistry and preclinical PET imaging of 68Ga-desferrioxamine radiotracers targeting prostate-specific membrane antigen
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted \(^18}\)F-DCFPyL in peripheral ganglia
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Development of inhibitors of the prostate specific membrane antigen (PSMA) for imaging and endoradiotherapy
Expression of prostate specific membrane antigen (PSMA) in breast cancer : = Die Expression des prostataspezifischen Membranantigens (PSMA) beim Mammakarzinom
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
Radiochemistry and preclinical PET imaging of 68Ga-desferrioxamine radiotracers targeting prostate-specific membrane antigen
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted \(^18}\)F-DCFPyL in peripheral ganglia
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]